Bruce Kagan, M.D.
Titles
Director, Adult Partial Hospitalization Program
Professor, Psychiatry and Biobehavioral Sciences
Member, Adult Psychiatry
Brain Research Institute
Neuroscience GPB Home Area
Contact Information
Email
bkagan@mednet.ucla.edu Phone
Work Phone Number:
310 206 2372
Address
Mailing Address:
760 Westwood PlazaLos Angeles, CA 90024
UNITED STATES
Biography
Bruce L. Kagan is a psychiatrist and neurophysiologist who joined the UCLA faculty in 1986. He became a full professor in 1998 and served as Director of the Psychiatry Research Residency Track from 1994-2004. He has chaired the Medical Institutional Review Board for Neuropsychiatry since 2004. He is currently Chief of Staff of the Resnick Neuropsychiatric Hospital. Dr. Kagan earned his BA cum laude in Molecular Biophysics and Biochemistry from Yale University. He received the MD and Ph.D. (physiology) degrees from the Albert Einstein College of Medicine. His laboratory research centers on channel forming toxins. He is currently studying channels formed by amyloid peptides in Alzheimer's and Parkinson's disease to elucidate the pathogenesis of these illnesses. He is also screening chemical libraries for channel blockers that could be used as therapeutic agents.Publications
A selected list of publications:
Kagan Bruce L, Jang Hyunbum, Capone Ricardo, Teran Arce Fernando, Ramachandran Srinivasan, Lal Ratnesh, Nussinov Ruth
Antimicrobial properties of amyloid peptides
Molecular pharmaceutics,
2012; 9(4):
708-17.
Connelly Laura, Jang Hyunbum, Arce Fernando Teran, Ramachandran Srinivasan, Kagan Bruce L, Nussinov Ruth, Lal Ratnesh
Effects of point substitutions on the structure of toxic Alzheimer's
β-amyloid channels: atomic force microscopy and molecular dynamics
simulations
Biochemistry,
2012; 51(14):
3031-8.
Capone Ricardo, Jang Hyunbum, Kotler Samuel A, Connelly Laura, Teran Arce Fernando, Ramachandran Srinivasan, Kagan Bruce L, Nussinov Ruth, Lal Ratnesh
All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid
Bilayers
Journal of chemical theory and computation,
2012; 8(3):
1143-1152.
Connelly Laura, Jang Hyunbum, Arce Fernando Teran, Capone Ricardo, Kotler Samuel A, Ramachandran Srinivasan, Kagan Bruce L, Nussinov Ruth, Lal Ratnesh
Atomic force microscopy and MD simulations reveal pore-like structures
of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to
the ion channel mechanism of AD pathology
The journal of physical chemistry. B,
2012; 116(5):
1728-35.
Kagan Bruce L
Membrane pores in the pathogenesis of neurodegenerative disease
Progress in molecular biology and translational science,
2012; 107(3):
295-325.
Capone Ricardo, Jang Hyunbum, Kotler Samuel A, Kagan Bruce L, Nussinov Ruth, Lal Ratnesh
Probing structural features of Alzheimer's amyloid-β pores in
bilayers using site-specific amino acid substitutions
Biochemistry,
2012; 51(3):
776-85.
Kagan Bruce L
Antimicrobial amyloids?
Biophysical journal,
2011; 100(7):
1597-8.
Kagan Bruce L, Thundimadathil Jyothi
Amyloid peptide pores and the beta sheet conformation
Advances in experimental medicine and biology,
2010; 677(14):
150-67.
Jang Hyunbum, Arce Fernando Teran, Ramachandran Srinivasan, Capone Ricardo, Azimova Rushana, Kagan Bruce L, Nussinov Ruth, Lal Ratnesh
Truncated beta-amyloid peptide channels provide an alternative
mechanism for Alzheimer's Disease and Down syndrome
Proceedings of the National Academy of Sciences of the United States of America,
2010; 107(14):
6538-43.
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., Lal, R.
Amyloid ion channels: A common structural link for protein-misfolding disease,
Proc Natl Acad Sci USA,
2005; 102(30):
10427-32.
Kagan, B.L.
Amyloidosis and protein folding,
Science,
2005; 307:
42-3.
Kagan Bruce L
Amyloidosis and protein folding
Science (New York, N.Y.),
2005; 307(5706):
42-3; author reply 42-3.
Kagan, B.L., Azimova, R., Azimov, R.
Amyloid peptide channels,
J Memb Biol,
2004; 202:
1-10.
Lin Meng-chin Allison, Kagan Bruce L
Electrophysiologic properties of channels induced by Abeta25-35 in
planar lipid bilayers
Peptides,
2002; 23(7):
1215-28.
Kagan, BL Hirakura, Y Azimov, R Azimova, R Lin, MC
The channel hypothesis of Alzheimer's disease: current status
Peptides. ,
2002; 23(7):
1311-5.
Kagan Bruce L, Hirakura Yutaka, Azimov Rustam, Azimova Rushana, Lin Meng-Chin
The channel hypothesis of Alzheimer's disease: current status
Peptides,
2002; 23(7):
1311-5.
Lin, M-C., Mirzabekov, T., Kagan, B.L.
Electrophysiologic Properties of Alpha Beta 25-35 channels,
Peptides,
2002; 23(7):
1215-28.
Hirakura, Y., Lin, M-C., Kagan, B.L.
The Channel hypothesis of Alzheimer's disease: current status,
Peptides,
2002; 23(7):
1311-5.
Hirakura, Y., Kagan, B.L.
The channel hypothesis of amyloidosis,
Cellular and Molecular Mechanics of Toxin Action,
2002; Vol. 5, (in press):
.
Hirakura Yutaka, Carreras Isabel, Sipe Jean D, Kagan Bruce L
Channel formation by serum amyloid A: a potential mechanism for
amyloid pathogenesis and host defense
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
2002; 9(1):
13-23.
Kagan, BL Hirakura, Y Azimov, R Azimova, R
The channel hypothesis of Huntington's disease
Brain research bulletin. ,
2001; 56(3-4):
281-4.
Hirakura, Y Kagan, BL
Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. ,
2001; 8(2):
94-100.